Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART

Bei Li,1 Leidan Zhang,2 Ying Liu,1 Jing Xiao,2 Xinyue Wang,2 Yuqing Wei,1 Lina Fan,3 Yujiao Duan,1 Guoli Li,4 Yaxian Kong,4 Hongxin Zhao1 1Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Infe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li B, Zhang L, Liu Y, Xiao J, Wang X, Wei Y, Fan L, Duan Y, Li G, Kong Y, Zhao H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
hiv
Acceso en línea:https://doaj.org/article/c457d80d4041497c9ef5a647b5dd6445
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c457d80d4041497c9ef5a647b5dd6445
record_format dspace
spelling oai:doaj.org-article:c457d80d4041497c9ef5a647b5dd64452021-11-16T18:47:50ZManifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART1178-6973https://doaj.org/article/c457d80d4041497c9ef5a647b5dd64452021-11-01T00:00:00Zhttps://www.dovepress.com/manifestations-and-related-risk-factors-of-thrombocyte-abnormalities-i-peer-reviewed-fulltext-article-IDRhttps://doaj.org/toc/1178-6973Bei Li,1 Leidan Zhang,2 Ying Liu,1 Jing Xiao,2 Xinyue Wang,2 Yuqing Wei,1 Lina Fan,3 Yujiao Duan,1 Guoli Li,4 Yaxian Kong,4 Hongxin Zhao1 1Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Infection, Beijing Ditan Hospital, Peking University, Beijing, People’s Republic of China; 3Department of Infectious Disease, The Tianjin Second People’s Hospital, Tianjin, People’s Republic of China; 4Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Hongxin ZhaoClinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8 Jing Shun East Street, Beijing, 100015, People’s Republic of ChinaEmail Drzhao66@ccmu.edu.cnBackground: At present, the thrombocyte abnormality is not well described before and after the initiation of antiretroviral therapy (ART). The purpose of this research is to investigate the dynamic changes and related risk factors of thrombocytopenia and thrombocytosis in HIV-infected individuals.Methods: We performed a real-world observational study among 6637 HIV patients who started ART from January, 2013 to August, 2020 at the Beijing Ditan Hospital. Hazard indicators linked with thrombocytopenia and thrombocytosis were analyzed by logistic/Cox regression.Results: The prevalence of thrombocytopenia and thrombocytosis was 2.65% and 5.85% among ART-naïve patients, respectively. Correlated risk factors: (thrombocytopenia) older age, coinfection with HBV, leucopenia, anemia, and CD4 count < 350 cells/uL; (thrombocytosis) WBC level ≥ 4.0 x 109/L, anemia, NLR ≥ 2.0, and CD4 count ≥ 350 cells/uL. As for the recovery rate, it was 86.6/54.2, 83.4/46.3, 66.0/35.1, and 65.3/ 33.9 per 100 PYFU in thrombocytopenia/thrombocytosis at different treatment period (12m, 24m, 36m, and 48m). While the new-onset incidence of thrombocytopenia/thrombocytosis at different ART period (12m, 24m, 36m, 48m, 60m, 72m, and 84m) was 0.25/7.2, 0.19/6.31, 0.16/4.74, 0.16/4.55, 0.16/4.48, 0.15/4.41, and 0.15/4.39. And the driving forces of thrombocytosis were antiretroviral treatment, female, overweight, and WBC level ≥ 4.0 x 109/L.Conclusion: In the medical practice, while paying attention to thrombocytopenia, clinicians should be highly vigilant about the thrombocytosis of HIV/AIDS patients, and related treatment strategies need to be further studied.Keywords: thrombocyte abnormalities, thrombocytopenia, thrombocytosis, HIV, antiretroviral therapyLi BZhang LLiu YXiao JWang XWei YFan LDuan YLi GKong YZhao HDove Medical Pressarticlethrombocyte abnormalitiesthrombocytopeniathrombocytosishivantiretroviral therapyInfectious and parasitic diseasesRC109-216ENInfection and Drug Resistance, Vol Volume 14, Pp 4809-4819 (2021)
institution DOAJ
collection DOAJ
language EN
topic thrombocyte abnormalities
thrombocytopenia
thrombocytosis
hiv
antiretroviral therapy
Infectious and parasitic diseases
RC109-216
spellingShingle thrombocyte abnormalities
thrombocytopenia
thrombocytosis
hiv
antiretroviral therapy
Infectious and parasitic diseases
RC109-216
Li B
Zhang L
Liu Y
Xiao J
Wang X
Wei Y
Fan L
Duan Y
Li G
Kong Y
Zhao H
Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART
description Bei Li,1 Leidan Zhang,2 Ying Liu,1 Jing Xiao,2 Xinyue Wang,2 Yuqing Wei,1 Lina Fan,3 Yujiao Duan,1 Guoli Li,4 Yaxian Kong,4 Hongxin Zhao1 1Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Infection, Beijing Ditan Hospital, Peking University, Beijing, People’s Republic of China; 3Department of Infectious Disease, The Tianjin Second People’s Hospital, Tianjin, People’s Republic of China; 4Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Hongxin ZhaoClinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8 Jing Shun East Street, Beijing, 100015, People’s Republic of ChinaEmail Drzhao66@ccmu.edu.cnBackground: At present, the thrombocyte abnormality is not well described before and after the initiation of antiretroviral therapy (ART). The purpose of this research is to investigate the dynamic changes and related risk factors of thrombocytopenia and thrombocytosis in HIV-infected individuals.Methods: We performed a real-world observational study among 6637 HIV patients who started ART from January, 2013 to August, 2020 at the Beijing Ditan Hospital. Hazard indicators linked with thrombocytopenia and thrombocytosis were analyzed by logistic/Cox regression.Results: The prevalence of thrombocytopenia and thrombocytosis was 2.65% and 5.85% among ART-naïve patients, respectively. Correlated risk factors: (thrombocytopenia) older age, coinfection with HBV, leucopenia, anemia, and CD4 count < 350 cells/uL; (thrombocytosis) WBC level ≥ 4.0 x 109/L, anemia, NLR ≥ 2.0, and CD4 count ≥ 350 cells/uL. As for the recovery rate, it was 86.6/54.2, 83.4/46.3, 66.0/35.1, and 65.3/ 33.9 per 100 PYFU in thrombocytopenia/thrombocytosis at different treatment period (12m, 24m, 36m, and 48m). While the new-onset incidence of thrombocytopenia/thrombocytosis at different ART period (12m, 24m, 36m, 48m, 60m, 72m, and 84m) was 0.25/7.2, 0.19/6.31, 0.16/4.74, 0.16/4.55, 0.16/4.48, 0.15/4.41, and 0.15/4.39. And the driving forces of thrombocytosis were antiretroviral treatment, female, overweight, and WBC level ≥ 4.0 x 109/L.Conclusion: In the medical practice, while paying attention to thrombocytopenia, clinicians should be highly vigilant about the thrombocytosis of HIV/AIDS patients, and related treatment strategies need to be further studied.Keywords: thrombocyte abnormalities, thrombocytopenia, thrombocytosis, HIV, antiretroviral therapy
format article
author Li B
Zhang L
Liu Y
Xiao J
Wang X
Wei Y
Fan L
Duan Y
Li G
Kong Y
Zhao H
author_facet Li B
Zhang L
Liu Y
Xiao J
Wang X
Wei Y
Fan L
Duan Y
Li G
Kong Y
Zhao H
author_sort Li B
title Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART
title_short Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART
title_full Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART
title_fullStr Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART
title_full_unstemmed Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART
title_sort manifestations and related risk factors of thrombocyte abnormalities in hiv-positive patients before and after the initiation of art
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/c457d80d4041497c9ef5a647b5dd6445
work_keys_str_mv AT lib manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT zhangl manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT liuy manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT xiaoj manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT wangx manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT weiy manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT fanl manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT duany manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT lig manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT kongy manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
AT zhaoh manifestationsandrelatedriskfactorsofthrombocyteabnormalitiesinhivpositivepatientsbeforeandaftertheinitiationofart
_version_ 1718426264636751872